Beta: Sign in
Shares outstandingAs of 2026-07-31 · filed common shares: 58.23M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 0.08%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 8.87%
Short ratioDays to cover, as published by FINRA: 9.11
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 77.60%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 73.60%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Rev growth (fwd)

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 75.42%
Operating marginTTM to Jun 26: 24.03%
Net margin: —
EBITDA margin: —
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 20.46%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 14.61%

Growth

Revenue growth (annual YoY): 21.51%
Revenue growth (latest qtr YoY): 30.32%
Revenue growth (fwd): Sign in
Net income growth (annual YoY)FY Dec 25 vs FY Dec 24: 9.07%
Net income growth (latest qtr YoY): 89.64%
EPS growth (fwd): Sign in
Net income growth (QoQ): 132.18%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

3.09

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $549.76M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $160.19M
Debt / equityas of Jun 26: 16.03%
Current ratioas of Jun 26: 3.48
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 3.33
Operating cash flowTTM to Jun 26: $355.07M
Free cash flowUnadjusted FCF = CFO − capex · TTM to Jun 26: $354.89M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 16.36

HRMY stock Statistics — Harmony Biosciences Holdings, Inc. filings, insiders & smart money · Instaport